They claim to have specially selected "conserved epitopes" that make their vaccine works against all variants. Said at FDA meeting. But NOT said at last week's ACIP meeting. So the spike is not identical. It also forms a trimer--as described in the Science article also.
They claim to have specially selected "conserved epitopes" that make their vaccine works against all variants. Said at FDA meeting. But NOT said at last week's ACIP meeting. So the spike is not identical. It also forms a trimer--as described in the Science article also.
Elsewhere, according to STAT, Novavax claimed that it was the adjuvant that made their vaccine have efficacy against Omicron. But FDA, again according to STAT, did not accept the company's efficacy data as it was derived from pilot vaccine lots made differently than the commercial product. So the vaccine was authorized with no data on efficacy against current strains.
They claim to have specially selected "conserved epitopes" that make their vaccine works against all variants. Said at FDA meeting. But NOT said at last week's ACIP meeting. So the spike is not identical. It also forms a trimer--as described in the Science article also.
Elsewhere, according to STAT, Novavax claimed that it was the adjuvant that made their vaccine have efficacy against Omicron. But FDA, again according to STAT, did not accept the company's efficacy data as it was derived from pilot vaccine lots made differently than the commercial product. So the vaccine was authorized with no data on efficacy against current strains.